周二盘中，吉利德科学（Gilead Sciences）股价大幅下挫5.02%，引发市场关注。这一跌势主要源于美国总统特朗普关于降低药品成本的最新表态。
据报道，特朗普表示将于下周公布降低药品成本的计划，这一消息引发了投资者对制药行业未来盈利能力的担忧。受此影响，包括吉利德科学在内的多家制药巨头股价均出现不同程度的下跌。
除吉利德科学外，其他制药公司如礼来（Eli Lilly）和艾伯维（AbbVie）股价下跌约3%，默克（Merck）下跌2.5%，安进（Amgen）下跌2.2%，辉瑞（Pfizer）下跌1.7%。标准普尔500指数医疗保健板块整体下跌1.5%，反映出投资者对制药行业的普遍担忧情绪。
分析人士指出，特朗普政府可能会推出针对制药业的关税提案，这可能会对行业造成一定影响。然而，一些专家认为，实际影响可能不会像市场反应那么严重。投资者将密切关注下周可能发布的具体政策细节，以评估其对吉利德科学等制药公司的长期影响。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.